A Phase II Toxicity End Point Trial (ICORG 99-09) of...

  • Main
  • 2017 / 10
  • A Phase II Toxicity End Point Trial (ICORG 99-09) of...
Clinical Oncology 2017 / 10

A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer

Cagney, D.N., Thirion, P.G., Dunne, M.T., Fleming, C., Fitzpatrick, D., O'Shea, C.M., Finn, M.A., O'Sullivan, S., Booth, C., Collins, C.D., Buckney, S.J., Shannon, A., Armstrong, J.G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Oncology
DOI:
10.1016/j.clon.2017.10.010
Date:
October, 2017
File:
PDF, 565 KB
english, 2017
Conversion to is in progress
Conversion to is failed